Literature DB >> 1275709

Inhibition of influenza RNA synthesis by virazole (ribavirin).

C Scholtissek.   

Abstract

Virazole (ribavirin) inhibits the RNA synthesis of an influenza A virus (fowl plague). Neither virion RNA nor complementary RNA are produced. Although the effect of virazole can be counteracted by guanosine the inhibitor does not interfere with the uptake or incorporation of labelled guanosine into chick embryo cells, nor does replacement of glucose by mannose amplify the effect of virazole. Thus virazole seems not to act via an interference with the GTP pool. Synthesis of Semliki Forest virus RNA is not affected by virazole.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1275709     DOI: 10.1007/BF01317961

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  10 in total

1.  Two different mechanisms of the inhibition of the multiplication of enveloped viruses by glucosamine.

Authors:  C Scholtissek; R Rott; H D Klenk
Journal:  Virology       Date:  1975-01       Impact factor: 3.616

2.  Effect of infection with enveloped viruses on nucleotide metabolism.

Authors:  G Hammer; R T Schwarz; C Scholtissek
Journal:  Virology       Date:  1976-03       Impact factor: 3.616

3.  An evaluation of a new antiviral agent "virazole" against influenza virus infections.

Authors:  T Suganuma; N Ishida
Journal:  Tohoku J Exp Med       Date:  1973-08       Impact factor: 1.848

4.  Detection of an unstable RNA in chick fibroblasts after reduction of the UTP pool by glucosamine.

Authors:  C Scholtissek
Journal:  Eur J Biochem       Date:  1971-12

5.  Synthesis in vivo of influenza virus plus and minus strand RNA and its preferential inhibition by antibiotics.

Authors:  C Scholtissek; R Rott
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

6.  Synthesis in vitro of RNA complementary to parental viral RNA by RNA polymerase induced by influenza virus.

Authors:  C Scholtissek
Journal:  Biochim Biophys Acta       Date:  1969-04-22

7.  Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.

Authors:  R W Sidwell; J H Huffman; G P Khare; L B Allen; J T Witkowski; R K Robins
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

8.  Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin).

Authors:  J S Oxford
Journal:  J Gen Virol       Date:  1975-09       Impact factor: 3.891

9.  Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.

Authors:  D G Streeter; J T Witkowski; G P Khare; R W Sidwell; R J Bauer; R K Robins; L N Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

10.  Physical and biological properties of influenza virus components obtained after ether treatment.

Authors:  F M DAVENPORT; R ROTT; W SCHAEFER
Journal:  J Exp Med       Date:  1960-11-01       Impact factor: 14.307

  10 in total
  18 in total

1.  NF-kappaB signaling differentially regulates influenza virus RNA synthesis.

Authors:  Naveen Kumar; Zhong-Tao Xin; Yuhong Liang; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

2.  Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate.

Authors:  B Eriksson; E Helgstrand; N G Johansson; A Larsson; A Misiorny; J O Norén; L Philipson; K Stenberg; G Stening; S Stridh; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  Failure of type 1 herpesvirus to develop resistance to ribavirin.

Authors:  L B Allen; C M Fingal
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

4.  Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.

Authors:  E De Clercq; M Cools; J Balzarini; R Snoeck; G Andrei; M Hosoya; S Shigeta; T Ueda; N Minakawa; A Matsuda
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

5.  Effects of ribavirin on the development of the Friend leukemia.

Authors:  U Opitz; H J Seidel; G Streissle
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

6.  Determination of ribonucleoside triphosphate pools in influenza A virus-infected MDCK cells.

Authors:  S Stridh
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

7.  Enhancement of activity against influenza viruses by combinations of antiviral agents.

Authors:  F G Hayden; R G Douglas; R Simons
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

8.  Lack of interference of guanosine with ribavirin aerosol treatment of influenza A infection in mice.

Authors:  V Knight; S Z Wilson; D W Alling; R V Moore; R M Longoria
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

9.  Effect of virazole (ribavirin) on tomato spotted wilt virus in two systemic hosts, tomato and tobacco.

Authors:  G De Fazio; J Caner; M Vicente
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

10.  Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cells.

Authors:  M J Browne
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.